key: cord-0912498-tzm1eaqg authors: da Cunha, Amanda Ramos; Antunes, José Leopoldo Ferreira; Martins, Manoela Domingues; Petti, Stefano; Hugo, Fernando Neves title: The impact of the COVID‐19 pandemic on oral biopsies in the Brazilian National Health System date: 2020-08-27 journal: Oral Dis DOI: 10.1111/odi.13620 sha: 0239be9b6b3038765380945ab22e981ffe8072cc doc_id: 912498 cord_uid: tzm1eaqg nan The COVID-19 pandemic is profoundly impacting health systems around the world. Since January 2020, the need to ensure care for cases of the new disease and to contain contagion has resulted in restrictions to health care provision (Remuzzi & Remuzzi, 2020) . The fear of being exposed to contamination by the new coronavirus may also have led individuals to avoid seeking for health care, even facing symptoms that should not be neglected (Olmo, Martínez, Ramos, Maroto, & Diaz, 2020) . Up until now, the health care community concentrated its efforts in the development of biosafety protocols (Centers for Disease Control and Prevention, 2020; Volgenant, Persoon, de Ruijter, & de Soet, 2020) , definition of what constitutes elective care during the pandemic (American Dental Association, 2020), and use of alternatives to traditional, 'in office' care, such as telehealth (Smith et al., 2020; Wosik et al., 2020) . Nevertheless, all these initiatives may not be sufficient to guarantee that the health systems worldwide provide timely care to all diseases, while it is struggling to contain and treat COVID-19. The diagnosis of oral cancer in early stages is one of the most critical factors related to the patient's survival (Dantas et al., 2016) and to the severity of mutilation that the individual can experience as part of surgical treatment. An incisional biopsy with histological assessment is the standard procedure for diagnosing oral cancer (Macey et al., 2015) . The American Dental Association (ADA) indicates that biopsies of abnormal tissues of the mouth constitute urgent dental care, being a condition that requires immediate attention (American Dental Association, 2020). In this scenario, we aimed to document the Brazil notified its first case of COVID-19 on February 29, and the number one death with a confirmed diagnosis occurred on March 17. The country reached the milestone of 1,000 deaths from this Accepted Article disease on April 10. At the time of this study's finish -in the first half of August -the country has accumulated more than 3 million reported cases and more than 104 thousand deaths (Ministry of Health of Brazil, 2020-c). The results of the present study showed an alarming decrease in the rate of mouth biopsies in all Brazilian regions in 2020, considering the average of March, April, and May, when compared with previous years (Figure 1 ). The comparison between the same periods of the years 2019 and 2020 indicated a decrease of 68.8% in these rates for the entire country, with all regions showing a decline of over 60% (Table 1) . This is a disquieting situation, as the real number of oral cancer cases and potentially malignant lesions that need diagnosis will not reduce in the pandemic scenario. For a disease with rapid evolution such as oral cancer, the lack of diagnostic procedures for a brief time will possibly result in diagnosis of tumors in more advanced stages. Late diagnosis of oral cancer reduces the chances of survival more than 200% (Seoane et al., 2016) ; this situation becomes even more relevant when we consider that, in a nonpandemic setting, only 40-50% of patients with oral cancer survive after five years (Dantas et al., 2016) . The most pronounced decline in 2020 occurred in the Southeast region, followed by the South (Figure 1 ). The comparison between 2019 and 2020 indicated a decrease of 75.6% in the Southeast (Table 1 ). Southeast is the most developed region of the country, with the best-structured health system (Bigoni, Antunes, Weiderpass, & Kjaerheim, 2019) , and was unable to maintain even half of its biopsy rate during the pandemic. North, Northeast, and Midwest had the lowest biopsy rates in 2019 (Figure 2 ), which makes their decrease even more alarming, as there was possibly not enough diagnosis even before the pandemic. When analyzed by sex and age, the decrease in biopsy rates was homogeneous between the different groups: 75.3%, 62.5%, and 62.8% of reduction, respectively, for children & adolescents, adults, and elderly males; 76.1%, 71.7%, and 70.0%, respectively, for the same age groups of female individuals. In line with these national data, the number of oral specimens collected in the Diagnostic Center for Oral Diseases (DCOD) of the Federal University of Pelotas, Brazil, between March and April 2020, was 69.9% lower than in the same period of the year 2019. More specifically, potentially malignant disorders (i.e., oral dysplasia and carcinoma in situ), and oral squamous cell carcinoma, that accounted for 8.8% and 7.4% of all diagnoses in the pre-COVID-19 era, decreased by 89% and 44%, respectively (Gomes, Schuch, Tarquinio, Etges & Vasconcelos, 2020) . Arbitrarily extending this local scenario to the whole country, 467 diagnoses of potentially malignant disorders and 194 diagnoses of oral squamous cell carcinoma would be missing in just three months, suggesting a considerable increase in the burden of oral cancer in Brazil in forthcoming years. This alarming situation is due to an overall general decrease in outpatient visits in oral medicine centers in Brazil. For example, in the A.C. Camargo Cancer Center of São Paulo, oral medicine visits decreased by 53.2% in the first six weeks of lockdown compared to the last six weeks before the lockdown (Alves et al., 2020) . These data reveal the worrying scenario that the COVID-19 pandemic has been outlining for oral cancer care and are compatible with some findings that are beginning to emerge in other countries. During This article is protected by copyright. All rights reserved the outbreak in Italy, a referral service for diagnosis of oral cancer in Turin diagnosed only 1/7 of the new cancer cases they expected to identify (Arduino, Conrotto & Broccoletti, 2020) . Following its natural history, oral cancer will continue to affect the population; the new reality will not impact its pace. However, the profoundly altered health system will miss several opportunities for early diagnosis and will have to manage this repressed demand in more advanced stages of the disease. Part of this pent-up demand may evolve into increase in mortality, that was stable in Brazil in the last decades (Perea, Peres, Boing, & Antunes, 2018) . When health systems collapse and fail, people respond with suffering and death. Monitoring the health system's productivity during the pandemic period is critical to reducing adverse outcomes at the population level. The pandemics' prejudicial impact on the system of health may linger for a more extended period than expected. Shedding light on the problem and raising awareness of the need to resume diagnostic routines is critical to oral cancer management and control; this report is a call for action, without This article is protected by copyright. All rights reserved Implication of COVID-19 in oral oncology practices in Brazil, Canada, and the United States What Constitutes a Dental Emergency? Files/ADA_COVID19_Dental_Emergency_DDS.pdf?utm_source=adaorg&utm_medium=covid-resources The outbreak of Novel Coronavirus disease (COVID-19) caused a worrying delay in the diagnosis of oral cancer in north-west Italy: The Turin Metropolitan Area experience. Oral diseases Describing mortality trends for major cancer sites in 133 intermediate regions of Brazil and an ecological study of its causes Guidance for Dental Settings Influence of Educational Level, Stage, and Histological Type on Survival of Oral Cancer in a Brazilian Population: A Retrospective Study of 10 Years Observation Global, regional, and national disability-adjusted lifeyears (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study Reduced demand for oral diagnosis during COVID-19: A Brazilian center experience Diagnostic tests for oral cancer and potentially malignant Accepted Article This article is protected by copyright. All rights reserved disorders in patients presenting with clinically evident lesions. The Cochrane database of systematic reviews SIGTAP -Sistema de Gerenciamento da Tabela de Procedimentos Ministry of Health of Brazil. (2020-b). Estimativa 2020 da Incidência de Câncer no Brasil do Instituto Nacional do Câncer José Alencar Gomes da Silva Ministry of Health of Brazil. (2020-c). Painel Coronavírus Perceived vulnerability to Coronavirus infection: impact on dental practice Trend of oral and pharyngeal cancer mortality in Brazil in the period of COVID-19 and Italy: what next? Early oral cancer diagnosis: The Aarhus statement perspective. A systematic review and meta-analysis Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19) Infection control in dental health care during and after the SARS-CoV-2 outbreak. Oral diseases